1 citations
,
January 2015 in “Journal of Dermatology and Venereology”
This study concluded that androgeneticalopecia may predict ischemic heart disease, and recommended that patients with AGA be screened for coronary artery disease.
This study, accepted for publication in the Journal of the American Academy of Dermatology, discusses the potential link between earlyandrogeneticalopecia, diabetes mellitus, and cardiovascular disease risks, exploring its role as an indicator in a cross-sectional analysis.
A young man faces severe hair loss in his early 20s, using treatments like dutasteride and minoxidil with little success, impacting his self-esteem and relationships. He considers hair systems and therapy as potential solutions.
N-Acetyl-Cysteine (NAC) was found to improve hair parameters in men with early-onset androgeneticalopecia, showing increased terminal hair count and decreased vellus hair count, with good tolerability. NAC, used alone or with minoxidil, may help due to its antioxidant properties, though its effectiveness can vary among individuals.
Diffuse thinning is often due to androgeneticalopecia, and DHT blockers like finasteride are recommended. Treatments mentioned include minoxidil, finasteride, dutasteride, and RU58841, with emphasis on starting early and using a holistic approach.
Clascoterone solution is in Phase III trials for male androgeneticalopecia, with results expected in the second half of 2025. Commercialization is anticipated in about 2-3 years, but there are concerns about delays and market expectations.
Androgeneticalopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.